Tender Details

Country: Brazil
Summary: Acquisition of Failed Highly Relevant Medicines (Electrolytes I, Antibiotics Iv, Controlled Ii, General Use V, General Use Vi, General Use Vii, General Use X, General Use Xi).
BRT Ref No: 128755112
Deadline: 05 Nov 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 90097/2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Object: Electronic Auction - Acquisition of highly relevant failed medicines (ELECTROLYTES I, ANTIBIOTICS IV, CONTROLLED II, GENERAL USE V, GENERAL USE VI, GENERAL USE VII, GENERAL USE X, GENERAL USE XI).
UASG code: 250059
Notice from: 10/23/2025 from 08:00 to 12:00 and from 13:00 to 17:00 Hs
Proposal Delivery: from 10/23/2025 at 08:00
CYCLOSPORINE, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 200
ASCIN, AMORPHOUS PRESENTATION, ASSOCIATED WITH SODIC POLYSULFONATE ASCIN, DIETHYLAMINE SALICYLATE COMPOSITION, CONCENTRATION 10MG + 10MG + 50MG/G, TOPIC GEL APPLICATION
Quantity: 1600
IRON III, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 2320
FLUTICASONE, PROPIONATE COMPOSITION, CONCENTRATION 50MCG/DOSE, PHARMACEUTICAL FORM ORAL AEROSOL - SPRAY
Quantity: 100
POTASSIUM PHOSPHATE, MONOBASIC AND DIBASIC COMPOSITION, CONCENTRATION 2 MEQ/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1944
GLYCEROL, DOSAGE 12%, CLISTER PRESENTATION
Quantity: 3000
GLYCEROL, DOSAGE 95%, CHILDREN'S SUPPOSITORY PRESENTATION
Quantity: 100
ALANYGLUTAMINE, COMPOSITION ASSOCIATED WITH L-ALANINE, CONCENTRATION 200 MG/ML, FORM PHARMACEUTICAL INJECTABLE SOLUTION
Quantity: 150
HALOPERIDOL, CONCENTRATION 2 MG/ML, TYPE USE ORAL SOLUTION-DROPS
Quantity: 124
HALOPERIDOL, DOSAGE 5 MG
Quantity: 200
LACTULOSE, CONCENTRATION 667 MG/ML, PHARMACEUTICAL SYRUP FORM
Quantity: 2156
LACTULOSE, CONCENTRATION 667 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 500
MACROGOL, ACTIVE INGREDIENT MACROGOL 3350, COMPOSITION SODIUM BICARBONATE, SODIUM AND POTASSIUM CHLORIDES, CONCENTRATION 13.125 G + 177.5 MG + 46.6 MG + 350.7 MG, PHARMACEUTICAL FORM POWDER FOR EXTEMPORARY PREPARATION
METHYLPREDNISOLONE, ACTIVE INGREDIENT SUCCINATE SALT, DOSAGE 125 MG, PRESENTATIONLYOPHILIZED POWDER + DILUENT, INJECTABLE
Quantity...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Acquisition of Failed Highly Relevant Medicines (Electrolytes I, Antibiotics Iv, Controlled Ii, General Use V, General Use Vi, General Use Vii, General Use X, General Use Xi). - Brazil Tender

The MINISTRY OF HEALTH, a Government sector organization in Brazil, has announced a new tender for Acquisition of Failed Highly Relevant Medicines (Electrolytes I, Antibiotics Iv, Controlled Ii, General Use V, General Use Vi, General Use Vii, General Use X, General Use Xi).. This tender is published on BrazilTenders under BRT Ref No: 128755112 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-05.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.